CLXT has been the subject of a number of other reports. Zacks Investment Research downgraded shares of Calyxt from a buy rating to a hold rating in a research report on Tuesday, July 23rd. National Securities reiterated a buy rating and set a $28.00 price target (down from $35.00) on shares of Calyxt in a research report on Thursday, August 8th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of $20.00.
CLXT stock opened at $7.71 on Thursday. The firm has a 50 day moving average of $7.21 and a 200-day moving average of $12.80. Calyxt has a 12-month low of $5.56 and a 12-month high of $19.30. The company has a current ratio of 15.96, a quick ratio of 15.94 and a debt-to-equity ratio of 0.23. The company has a market cap of $251.43 million, a price-to-earnings ratio of -8.47 and a beta of 2.50.
Calyxt (NASDAQ:CLXT) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.32) by $0.03. Calyxt had a negative net margin of 5,509.93% and a negative return on equity of 36.21%. The company had revenue of $0.41 million during the quarter, compared to the consensus estimate of $0.30 million. Sell-side analysts forecast that Calyxt will post -1.11 earnings per share for the current fiscal year.
Several hedge funds have recently bought and sold shares of the company. Bank of America Corp DE lifted its position in shares of Calyxt by 14.8% during the 4th quarter. Bank of America Corp DE now owns 10,300 shares of the company’s stock valued at $106,000 after acquiring an additional 1,330 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Calyxt by 56.5% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 21,848 shares of the company’s stock worth $273,000 after purchasing an additional 7,887 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Calyxt by 52.3% during the 2nd quarter. Wells Fargo & Company MN now owns 24,679 shares of the company’s stock worth $309,000 after purchasing an additional 8,475 shares during the last quarter. Gilder Gagnon Howe & Co. LLC acquired a new position in shares of Calyxt during the 1st quarter worth approximately $172,000. Finally, Granite Investment Partners LLC raised its position in shares of Calyxt by 87.9% during the 1st quarter. Granite Investment Partners LLC now owns 21,801 shares of the company’s stock worth $383,000 after purchasing an additional 10,196 shares during the last quarter. Institutional investors own 28.05% of the company’s stock.
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.
Further Reading: How analysts view the yield curve
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.